The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2022 | Highlights from the ERIC International Meeting
Paolo Ghia, MD, Università Vita-Salute San Raffaele, Milan, Italy, shares his excitement for the ERIC meeting, highlighting the key features of this congress. Prof. Ghia explains that this meeting aims to bring world experts in chronic lymphocytic leukemia (CLL) together to interact in search of new ideas and to draw the lines of future research and treatment innovations. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
